chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Regular menstrual cycle prior to vax at 28 days, 4 days max.  LMP was 3/24.  Started excessively heavy menstrual bleeding on 4/9 - 2 days after 2nd vax.  For 4 days had to change ultra tampons more than every 2 hours.  Bled/spotted for 10 days.  Have been having periods every 2 to 3 weeks ever since with them lasting 7+ days.
Slightly dizzy after injection  45 minutes after,  Felt able to drive straight home.  Rested on couch & more dizzy with veritigo up to 2 hours after resting.
This spontaneous report was received from a pharmacist, referring to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 23-OCT-2015, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB (Lot# L016427; expiration date: 13-APR-2017) (dose and route of administration were not provided). Concomitant therapies were not reported. No adverse effects reported. The pharmacist explained that the RECOMBIVAX HB doses were not involved in a previous temperature excursion and this time the temperature and time frame were: 1.4C for 22 hours 52 minutes and 8.6C for 112 hours 5 minutes. This is one of several reports received from the same source (original report 1602USA004808). Additional information has been requested.
"wouldn't walk, spacey, drooling, staggered like was drunk, fever 104, all per mom, no sz activity noted by parents;
Itchy throat 3 days after shot (took Benadryl).  Hoarse voice for the next 2 days (took Loratidine then Allegra).  Post nasal drip and coughing for the next 7 days (took Mucinex DM).  Still coughing every now and then to clear throat.
she has a rash all over her chest and kind of on her back; Inappropriate schedule of vaccine administered; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 36 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 27Aug2021 10:15 (Lot number: EW0183) at the age of 36 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose:1, Lot: EW0164., Anatomical location: left arm), administration date: 25Jun2021, when the patient was 36 years old, for COVID-19 immunization, reaction(s): "It is explained that there was some splotchiness between the first and second shot", "She thought it was dry skin". The following information was reported: RASH (non-serious) with onset 30Aug2021, outcome "not recovered", described as "she has a rash all over her chest and kind of on her back"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 27Aug2021 10:15, outcome "unknown", described as "Inappropriate schedule of vaccine administered". Therapeutic measures were not taken as a result of rash.  Additional information: It was reported that Caller received her 2nd dose of the Pfizer covid vaccine/Comirnaty on 27Aug2021 and developed a rash on her chest and back. Reporter asking, Why did I get a rash? I'm a little worried. My 2nd shot was on Friday 3 days ago. Upon Follow-up Caller, reporting on the Pfizer Covid vaccine, the shot second given on 27Aug2021. The caller states today she has a rash all over her chest and kind of on her back. She would like to know why this happened. Primary Healthcare: Caller does not know how to spell the doctors name, captured as it sounded. No phone or email known. First dose was on 25Jun2021, given early in the day but the exact time is unknown, in the left arm, Lot: EW0164. NDC and Expiry unknown. Second dose was on 27Aug2021 at around 10:15am in the left arm, Lot: EW0183. NDC and Expiry unknown. Caller remarks she will call the primary doctor. It is explained that there was some splotchiness between the first and second shot but today noticed it was worse and red. She clarifies the splotchiness went away after the first dose; it started a few days after getting the first dose and last a few days then went away. She thought it was dry skin. Now after the second dose, she notices it is worse than after the first dose. It doesn't itch but is red and there. She is not allergic to anything.   No follow-up attempts are possible. No further information is expected.
Current recommended age for Pfizer covid vaccine is ages 16 and up. Patient does not meet criteria due to being only 15 years of age. Patient/parents were advised to wait for second dose, however, patient returned and received second dose before the age of 16.
After receiving the first dose of the Pfizer\BioNTech vaccine (7/19/21) my period was 5 days late. My period is never late. I am 37 years old and the only times my period has been late is when I have been pregnant with my three children. After receiving the second dose of the Pfizer\BioNTech vaccine (8/9/21), my period was again late. There are no extenuating circumstances, no stressors during that time that would cause my period to be late. I have also noticed a faint pain in/around my heart that is not going away. I did not have this pain or feel anything similar to it before receiving the vaccines.
I have had eczema my whole life,  but have had it controlled since moving nine years ago. The ability to control this condition and limit it to my hands vanished the last quarter of 2021. Shortly after receiving the Pfizer Booster (10/01/2021), various skin conditions that had never occurred began to surface and old conditions started with renewed vengeance.  Skin bumps and lesions to my face began. Severe plaque psoriasis to my scalp, neck and forehead and redness to my hands and forehead.  A skin abscess (boil) that bled started in my left groin and inhibited my ability to walk. When the skin abscess became unmanageable I sought medical help (01/18/2022) at Dermatology.
After first dose of Pfizer vaccine, I had a skin rash on the backs of both hands; small "bumps" in various isolated patches.  These went on for about a week and a half but had gone away by the second dose.  I used no product to control the itch for the first dose.  The second dose was on 5/1/21, lot # EW0173, same provider.  The rash is considerably worse after this dose.  Now I am getting large "bumps"  of various shapes that crop up all over my body, but usually disappear over the course of the day only to crop up at some other location.  These are irregular shaped raised areas, itchy, sometimes in lines, sometimes clusters.  Occasionally they are the tiny bumps like I got after the first dose.  The larger "welts" are usually about the diameter of a dime, but irregular in shape.  One of the more unique ones was like a worm shaped line, about 7 cm long but only 5mm wide or so.  At any given moment I usually have 4 or so areas on my body, usually hands, arms, trunk or neck area, that last about 6-12 hours before disappearing and a new batch crops up somewhere else.  I am using a topical Benydryl gel to control the itchiness and that is working very well, and makes any given spot disappear more quickly.  It's nearly 4 weeks after dose #2 but it's not occurring less often like it did after the first dose yet.  I am hoping this whole body reaction will eventually run its course and the rash goes away.  One other detail:  the Lisinopril I had been taking was new-- this could be a reaction to it as well.  I started my first course of it at 10mg one week before the first dose.  I saw no adverse reaction of any kind during that week.  Then I got the first dose of vaccine and the hand rash began 2 days later.   On April 30, I was switched to the final regular dose of Lisinopril of 20mg and the very next day got dose #2 of the vaccine.  The new rash once again started a few days later and got worse over time.   So could be associated with the Lisinopril but my sense it more likely the vaccine given the first week of the med had no reaction of any kind,
Pt. received Gardasil on March 24, 2008 at the Health Center.  Pt. had a positive preg. test 03-27-08 at school health care.
TENDERNESS AT INJECTION SITE// STIFF NECK AT BASE OF SKULL LASTED 2HR Narrative:
Staff member received influenza vaccine from employee health nurse.  Received flu vaccine in right deltoid on 9/11/20. Later in the day developed enlarged painful lymph node. Tenderness & swelling persisted for 2-3 days and gradually subsided.
Fainting, possible seizure, unconsciousness, severe chills, nausea, aches/flu like symptoms
achiness; getting sick; Could not even sleep because of the achiness; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received second dose, bnt162b2 (BNT162B2; PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Batch/Lot number: not reported), via an unspecified route of administration on 16Feb2021 (at the ag of 73 years-old) as dose 2, single for COVID-19 immunisation. Medical history included Diabetes and cholesterol from an unknown date and unknown if ongoing. Concomitant medication(s) included janumet for an unspecified indication, start and stop date were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection) on 16Jan2021 as single dose for covid19 immunisation. The patient experienced achiness, getting sick, could not even sleep because of the achiness on an unspecified date. Patient stated that she was kind of just wondering, she already got her second shot, and she got it last Tuesday and this week, it was not until now that she was feeling, thinks she was not sure, if that was side effect from the shot. Like towards the evening, she felt achy, it's like she was got sick, but then she wake up in the morning okay. Would she still be getting side effects from second shot, well, last night, after the second one. But the first one, she started getting sick the next day. The patient underwent lab tests and procedures which included blood work: everything was good on an unspecified date. Tylenol were taken as a result of achiness. The outcome of events was unknown.  No follow-up attempts are needed. Information about lot/ batch number cannot be obtained.
I got the two shots and still got shingles/suspected  vaccination failure; Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   Concurrent medical conditions included arthritis (was on arthritis fighting drugs).   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.  It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: This case was reported by the patient for herself or himself. The age at vaccination was not reported. The patient stated that got the two shots of shingles vaccine and still got shingles. The patient also stated that the Arthritis fighting drugs lower your immunity and might make the vaccine ineffective. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory test confirming shingles were unknown at the time of reporting.
Information has been received from a licensed practical nurse concerning a 4 year old male with no known drug allergies who on 04/27/2002 was revaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot # 64218L/0183M).  There was no concomitant medication.  On 04/27/2002, "about 20 minutes after vaccination," the patient began to itch, cough, and "became red from his shoulders up."  The patient was given a teaspoon of cetirizine (Zyrtec).  The symptoms persisted and the patient began to have difficulty breathing.  The patient was sent to the local emergency room, and was treated and released with all symptoms resolved within four hours.
INTENSE MUSCLE ACHES; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. The batch number was not reported. Procedure, no follow-up will be required for this case. No concomitant medications were reported. On 07-APR-2021, the subject experienced intense muscle aches. On 08-APR-2021 02:00, treatment medications included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from intense muscle aches. This report was non-serious.
Rash (macular rash all over the torso , back and limbs , sparing the soles and palms) -  Treated with benadryl as needed for itchiness .
Headache; Diarrhea; increased bowelmovements; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6206), via an unspecified route of administration in the right arm on 16Mar2021 at 15:00 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Medical history included depression, migraine, chronic shoulder issue, penicillin allergy and allergy to sulpha. Concomitant medications included galcanezumab (EMGALITY), topiramate (MANUFACTURER UNKNOWN), pregabalin (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN) and escitalopram oxalate (LEXAPRO); all for unknown indications from unknown dates. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNSPECIFIED) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021, the patient experienced headache which lasted for two weeks, diarrhea and increased bowel movements, which lasted for several days. The events resulted in doctor or other healthcare professional office/clinic visit. The patient received IMODIUM for bowel movements and prednisone for headache as a treatment. The clinical outcome of the events headache, diarrhea and the increased bowel movements was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
p/vax pt exp dizziness, felt faint, went limp, devel seizure, hypertensive
After dose 3/20, her arm became swollen and painful and her ears were ringing. She did not seek medical attention until 3/22 when she noticed a red dotted non-pruritic rash that was spreading. Patient stated that the maculopapular rash clustered under her breasts and blanched. Her primary doctor recommended she be seen at urgent care. She was prescribed ZYRTEC and ranitidine and MEDROL dose pack (5 day). She reported improvement after starting the steroid with near resolution after the last dose of steroid. Only new medication has been a supplemental sleep aid "Gaba gamma aminobutyric ".
We have had 5 cases in the past 2 months of only the diluent being administered to the patient.
no previous signs or sx; died in sleep; arrived @ hosp ER 825 & was pronounced dead;
Swelling around ears and nose, red rash on neck with raised red bumps, swelling of both right nostril and both ears, bumps behind one ear
Expressed dizziness following shot. Nurse assisted her to lower head. Brief loss of consciousness (30-45 seconds) and awakened and color pale. BP 90/50-deep breathing done. Remained with head down 3-4 minutes. Felt less dizzy; took water and BP 104/58 and ambulated to waiting area. Supervised by parent. Dismissed 4:05 PM.
had an US and CT, which showed a mildly enlarged/inflamed liver; had an US and CT, which showed a mildly enlarged/inflamed liver; discomfort; This is a spontaneous report from a contactable consumer (parent). A 17-years-old male patient received BNT162B2 (COMIRNATY, solution for injection), dose 2 via an unspecified route of administration on 04Apr2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received BNT162B2 (COMIRNATY, solution for injection), dose 1, SINGLE on 14Mar2021 for covid-19 immunisation. On an unknown date in 2021, patient experienced discomfort, so had an ultrasound and CT, which showed a mildly enlarged/inflamed liver. Reporter said maybe there was a link. At the time of this report, the outcome of events was unknown.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Patient states that after she went out to lunch that day after being vaccinated, she had blurred vision which she described as being bad enough that one could not drive. She also felt woozy and felt nauseated. This lasted for approximately 5 minutes. Once she got home she slept for about 3 hours and felt fine after that. She states she had no reaction with any previous dose, aside from a sore arm. She called our pharmacy the day after vaccination to report the adverse event after calling her pharmacy and her prescriber. They instructed her to contact us to report the event.
Pfizer vaccine- unknown lot number and dose number  Reaction documented: anaphylaxis, high
Patient called and stated she could not sleep last night due to severe "unbearable" itching on her back.   She stated initially no rash, but later said there were a few small red dots on her back.  She denied having a fever, difficulty breathing, itching in other areas of her body, or any other rash.  She stated possible stomach discomfort, but was not sure if this was related to the vaccine.
This case is 1 of a cluster of 3 patients' who experienced similar adverse events following vaccination with MENACTRA. Initial report received from a health care professional on 25 May 2010. An 11-year-old male child, with cellulitis of the toe at time of vaccination and no other pre-existing medical history, receiving the following injections on 18 May 2010: A right deltoid intramuscular injection of MENACTRA, lot number U3357BA, and a left deltoid intramuscular injection of ADACEL, lot number sanofi pasteur Ltd. C3312 and lot number sanofi pasteur Inc. U3051AA. The patient developed redness, swelling, itchiness at the injection site on the right upper arm which was also warm to the touch. The patient was given AUGMENTIN for 10 days. The patient's diagnosis was cellulitis. The outcome for the events was reported as recovered. Follow-up information was received from a health care professional on 19 July 2010 reported that the patient had no limitation to the arms. The patient had no laboratory work ordered. The onset date for the event was reported as 20 May 2010. The outcome remained recovered for the events. Documents held by sender: None.
started with adverse reaction of chills, headache, severe joint pain, nausea 2 days post vaccination.  She reported to us after 2 weeks of her symptoms as she was still experiencing migraines unlike her normal issues and she was experiencing nausea suddenly at different times of day and still did not feel normal post vaccination.  I did follow up with her after 2 and a 1/2 weeks and she said she did wake up feeling good and thinks the symptoms have resolved.
Chills and shakes night of vaccination 11/22/2005, arm upper part red and hot, terrible pain arm remained red and sore, assessed by Dr 11/25/2005 RX ASA, cold packs.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 75-year-old male patient who received SHINGRIX for prophylaxis. On 28th March 2019, the patient received the 1st dose of SHINGRIX (intramuscular). On 28th March 2019, less than a day after receiving SHINGRIX, the patient experienced injection site pain. SHINGRIX was continued with no change. On an unknown date, the outcome of the injection site pain was not recovered/not resolved. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were provided as follows: The patient experienced injection site pain after receiving a dose of SHINGRIX. There was consent to follow up.
Initial report received from a health care professional on 12 November 2008. A male patient (age not reported) experienced syncope after receiving an ADACEL injection (lot number, route/site of administration and date of administration not reported). The patient passed out and injured his face in the fall. Patient outcome was reported as "unknown". The reporter declined to give further information. Documents held by sender: None.